Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer
Ryo Tsumura(National Cancer Center Hospital East), Masahiro Yasunaga(Japan Clinical Cancer Research Organization)
Cited by 2
Related Papers
Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific molecule
|Cancer Science|2018|22
Potential Mechanisms of Interstitial Lung Disease Induced by Antibody–Drug Conjugates Based on Quantitative Analysis of Drug Distribution
|Molecular Cancer Therapeutics|2024|13